Latest News Archive
Please select Category, Year, and then Month to display items
31 January 2018
Photo FNB Varsity Cup
Lubabalo Dobela, Shimlas flyhalf (with the ball), played a key role in the Shimlas’ win over Tuks in the first round of the 2018 Varsity Cup.
The Shimlas made a huge statement in their opening match of the 2018 Varsity Cup when they defeated last year’s champions at the Tuks Rugby Stadium in Pretoria.
The Free State students won the encounter against Tuks by 19-17 on Monday.
Tuks, who beat Shimlas twice last year, first in the group stage by 65-19, and then by 28-21 in the semifinals, were regarded as the hot favourites. The match was played in wet conditions which many thought would suit the home team better.
Determination carries team to win
But a young and inexperienced Shimlas team with 11 players making their debut in the competition proved that big hearts and guts count for just as much. It was only their third win in Pretoria in the 11th year of the competition and their second victory over Tuks since 2012.
As expected, both teams tightened up their approach. Shimlas struck back from a 0-5 deficit soon after the first strategy break as big and speedy wing Francois Agenbag stormed down the touchline to score a seven-point try. Flyhalf Lubabalo Dobela was on hand to convert and hand his team a 9-5 lead at the break.
Flyhalf stars in debut
The Shimlas extended their lead within five minutes of the restart as flank Benji Janse van Vuuren crashed over in the corner for a converted try. Dobela, one of the debutants who was named Player that Rocks (Player of the Match), controlled the match like a seasoned veteran. Apart from two difficult conversions from the touchline, he also slotted a penalty goal.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”